Diosmin + Hesperidin
Pregnancy & Lactation.
Hemorrhoids, Piles, Chronic venous disease
It is contra-indicated in patients, who have shown hypersensitivity to any of the substances present in the drug.
N/A
Possible side-effects to be observed: cutaneous allergies, gastrointestinal disorders, headaches and flushes.
Diosmin and hesperidin are flavonoid compounds. When used together, they prolong the vasoconstrictor effect of noradrenaline on the venous wall, thus increasing venous return and reducing venous hyperpressure present in patients with chronic venous disease. They also improve lymphatic drainage and protect the microcirculation from inflammation. Diosmin and hesperidin are used together in the treatment of venous disease e.g. chronic venous disease and haemorrhoidal disease.
Metabolism of metronidazole may be reduced by concurrent admin of diosmin.
N/A
Oral Chronic venous disease Adult: Each tablet containing disomin 450 mg and hesperidin 50 mg: 2 tablets daily for 2-6 months. Each tablet containing disomin 900 mg and hesperidin 100 mg: 1 tablet daily for 2-6 months. Haemorrhoids Adult: Acute attack: disomin 450 mg and hesperidin 50 mg: 6 tablets daily for the 1st 4 days followed by 4 tablets daily for the next 3 days. DS Tablet: disomin 900 mg and hesperidin 100 mg: 1 tablet 3 times daily for 4 days then 2 times daily for 3 days and Once daily as maintenance Chronic haemorrhoids: disomin 450 mg and hesperidin 50 mg: 2 tablets daily for 3 months. DS Tablet: disomin 900 mg and hesperidin 100 mg: 1 tablet once daily for 3 months
N/A
N/A
N/A
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.